Biodel Inc.
6 Christopher Columbus Avenue
Danbury
Connecticut
06810-7352
United States
Tel: 203-798-3600
Fax: 203-798-3601
Website: http://www.biodelinc.com/
Email: info@biodelinc.com
164 articles about Biodel Inc.
-
Albireo Completes Transaction With Biodel To Create Publicly Traded Company Focused On Orphan Pediatric Liver Diseases
11/4/2016
-
Biodel Announces Adjournment Of Annual Meeting Until Thursday, October 27, Urges Stockholders To Vote
10/25/2016
-
Biodel Lays Off Another 15 Employees in Restructuring
1/29/2016
-
Struggling Biodel to Chop 30% of Workforce While Launching and Re-Launching Clinical Trials
11/4/2015
-
Biodel Announces Removal of Partial FDA Clinical Hold on Phase IIb Study 3-250
10/12/2015
-
Biodel Inc.'s Insulin Drug Found Effective In Phase 2 Trial
8/11/2014
-
Biodel Inc. Enters Into $15 Million Equity Commitment With Lincoln Park Capital
7/28/2014
-
Biodel Inc. To Report Second Quarter Fiscal Year 2014 Financial Results On May 13, 2014
5/8/2014
-
Biodel Inc. Announces Collaboration Agreement With HEC Pharm for Development of Ultra-Rapid-Acting Insulin Aspart Formulation
4/23/2014
-
Biodel Inc. Announces Commercial Manufacturing Agreement With Emergent BioSolutions For Glucagon Rescue Product
3/6/2014
-
Biodel Inc. To Present At The 26th Annual ROTH Conference
3/4/2014
-
Biodel Inc. Announces Plans To Advance BIOD-531 Based On Positive Clinical Trial Results
2/13/2014
-
Biodel Inc. Reports First Quarter Fiscal Year 2014 Financial Results
2/7/2014
-
Biodel Inc. To Report First Quarter Fiscal Year 2014 Financial Results On February 6, 2014
2/6/2014
-
Biodel Inc. To Present At Upcoming Conferences
2/5/2014
-
Biodel Inc. Reports Fourth Quarter Fiscal Year 2013 Financial Results
12/19/2013
-
Biodel Inc. Announces Commercial Supply Agreement With Becton, Dickinson and Company For Liquid Glucagon Rescue Device
12/17/2013
-
Biodel Inc. To Report Fourth Quarter Fiscal Year 2013 Financial Results On December 18, 2013
12/12/2013
-
Biodel Inc.'s BIOD-123 Achieves Primary Endpoint in Phase 2 Clinical Trial Demonstrating Glycemic Control Comparable to Humalog®
9/9/2013
-
Biodel Inc. Reports Third Quarter Fiscal Year 2013 Financial Results
8/13/2013